Dr. Kass Newman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Memorial Sloan Kettering Cancer Center
530 East 74th Street
New York, NY 10021Phone+1 646-608-4331- Is this information wrong?
Summary
- Dr. Samantha Kass Newman is an endocrinologist at Memorial Sloan Kettering Cancer Center in New York, NY. She received her medical degree from Georgetown University School of Medicine, completed her residency at NYU, her chief residency at MSKCC, and her fellowship at Mount Sinai Medical Center. She specializes in thyroid cancer and is experienced in general endocrinology.
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2019 - 2021
- New York Presbyterian Hospital (Cornell Campus)Chief Residency, Internal Medicine, 2018 - 2019
- NYU Grossman School of MedicineResidency, Internal Medicine, 2015 - 2018
- Georgetown University School of MedicineClass of 2015
Certifications & Licensure
- NJ State Medical License 2021 - 2025
- NY State Medical License 2016 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 6 citationsTaking Control of Castleman Disease: Leveraging Precision Medicine Technologies to Accelerate Rare Disease Research.Samantha Kass Newman, Raj Jayanthan, Grant W. Mitchell, Jossie A. Carreras Tartak, Michael P. Croglio
The Yale Journal of Biology and Medicine. 2015-11-24 - 6 citationsInvasion of a Recurrent Laryngeal Nerve from Small Well-Differentiated Papillary Thyroid Cancers: Patient Selection Implications for Active Surveillance.Samantha K Newman, Victoria Harries, Laura Y. Wang, Marlena McGill, Ian Ganly
Thyroid. 2021-10-29 - 4 citationsPhase II Study of a Non-Platinum–Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung AdenocarcinomasMaria Catherine Pietanza, Matthew D. Hellmann, John J. Fiore, Stephanie Smith-Marrone, Ethan Basch
Journal of Thoracic Oncology. 2016-06-01
Professional Memberships
- Endocrine SocietyMember
Hospital Affiliations
- Hackensack Meridian Health Hackensack University Medical CenterHackensack, New Jersey
- Memorial Sloan Kettering Cancer CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: